Valuation: Acarix AB

Market Cap 206M 20.84M 18.69M 17.08M 15.6M 29.38M 1.96B 30.31M 82.11M 1.05B 78.23M 76.55M 3.3B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 206M 20.84M 18.69M 17.08M 15.6M 29.38M 1.96B 30.31M 82.11M 1.05B 78.23M 76.55M 3.3B EV / Sales 2026 *
14.7x
EV / Sales 2027 * 6.44x
Free-Float
89.13%
Yield 2026 *
-
Yield 2027 * -
1 day-3.26%
1 week-7.68%
Current month-7.68%
1 month-22.79%
3 months-32.52%
6 months-37.48%
Current year-38.06%
1 week 0.16
Extreme 0.16
0.18
1 month 0.16
Extreme 0.16
0.21
Current year 0.16
Extreme 0.16
0.33
1 year 0.16
Extreme 0.16
0.34
3 years 0.16
Extreme 0.16
0.6
5 years 0.16
Extreme 0.16
1
10 years 0.16
Extreme 0.16
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-3.26%-7.68%-39.19%-30.25% 20.84M
+2.63%-0.32%+21.37%+51.28% 257B
+1.73%-0.85%+9.67%+16.14% 162B
-3.36%+4.81%-19.14%+62.47% 157B
-4.23%+1.83%-57.26%-18.06% 61.96B
+1.31%+11.01%+22.48%+53.52% 58.73B
-0.76%+4.13%+3.16%-6.90% 55.42B
+1.73%-0.06%+19.09%+58.10% 49.27B
-2.05%-2.95%+3.01%+56.47% 49.18B
+1.00%-1.11%+23.11%+75.55% 44.96B
Average -0.53%+0.46%-1.37%+31.83% 89.59B
Weighted average by Cap. +0.26%+1.20%+4.62%+40.52%

Financials

2026 *2027 *
Net sales 14M 1.42M 1.27M 1.16M 1.06M 2M 133M 2.06M 5.58M 71.07M 5.32M 5.2M 224M 32M 3.24M 2.9M 2.65M 2.42M 4.57M 304M 4.71M 12.76M 162M 12.16M 11.9M 513M
Net income -30.8M -3.12M -2.8M -2.56M -2.33M -4.39M -293M -4.53M -12.28M -156M -11.7M -11.45M -494M -15.3M -1.55M -1.39M -1.27M -1.16M -2.18M -146M -2.25M -6.1M -77.67M -5.81M -5.69M -245M
Net Debt - -
Projected Income Statement - Annual - Acarix AB
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
06/11/26 SEK 0.1660 -3.26% 1,343,629
05/11/26 SEK 0.1716 -4.56% 5,717,519
04/11/26 SEK 0.1798 +1.58% 1,360,437
03/11/26 SEK 0.1770 -1.67% 2,178,264
02/11/26 SEK 0.1800 +0.11% 1,558,427

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Acarix AB
  1. Stock Market
  2. Stocks
  3. ACARIX Stock